An exacerbation of myasthenia gravis may require a visit to an intensive care unit; however, risk factors for admission and prognosis haven’t been well studied. With this in mind, researchers in ...

An exacerbation of myasthenia gravis may require a visit to an intensive care unit; however, risk factors for admission and prognosis haven’t been well studied.

Alexion to present seven abstracts, including four oral presentations, from its leading rare neurology portfolio at EAN 2025: Cambridge, UK Monday, June 23, 2025, 13:00 Hrs [IST] ...

Approval in Myasthenia gravis in key markets could eventually add more than ... These patients are at an increased risk of disease exacerbations and crises that may require hospitalisation and ...

Telitacicept is a dual-targeting agent that attaches to and blocks the effects of 2 key signaling proteins, B-lymphocyte ...

Myasthenia Gravis (MG) is a rare neurological disorder that severely impairs muscle movement and can lead to life-threatening complications. While existing C5 inhibitors have contributed to ...

Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular disorder myasthenia gravis ...

B, cardiopulmonary physical therapist and director of the Pulmonary Wellness and Rehabilitation Center in New York City, reflects on how the reality of COVID-19 infection proved far more complex than ...